← Back to Clinical Trials
Recruiting NCT07109947

NCT07109947 Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07109947
Status Recruiting
Phase
Sponsor Aswan University
Condition Miscarriage
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-07-10
Primary Completion 2025-12-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Letrozole 2.5mg

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2025-07-10 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Abortion is one of the most common complications of pregnancy. Missed abortion is a type of abortions, occurs in 15%-20% of clinically diagnosed pregnancies and is defined as the retention of pregnancy products in the uterus for several days or weeks after death of the fetus.

Eligibility Criteria

Inclusion Criteria: * Missed or anembryonic pregnancy. * Gestational age from 4 weeks to 26 weeks of pregnancy (confirmed by ultrasound scanning on first day of admittance). * Hemoglobin level more than 9g/l. * Closed cervix. * No product of conception in the cervical canal. Exclusion Criteria: * Previous attempt to terminate the pregnancy. * Molar pregnancy * Abnormal uterine lesions such as fibroids or congenital mal formations. * Pregnancy despite of intrauterine contraceptive device. * Medical disorders as cardiac, renal or hemorrhagic diseases. * BMI more than 35 kg/m2. * Known hypersensitivity to any of the medication used.

Contact & Investigator

Central Contact

Arwa Ashraf Saeed, MSC

✉ Arwa170439@aswu.edu.eg

📞 +201013302339

Principal Investigator

Hani Ahmed Farouk, Assist.Prof.

STUDY CHAIR

Obstetrics and Gynecology,Faculty of Medicine,Aswan University

Frequently Asked Questions

Who can join the NCT07109947 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Miscarriage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07109947 currently recruiting?

Yes, NCT07109947 is actively recruiting participants. Contact the research team at Arwa170439@aswu.edu.eg for enrollment information.

Where is the NCT07109947 trial being conducted?

This trial is being conducted at Aswān, Egypt.

Who is sponsoring the NCT07109947 clinical trial?

NCT07109947 is sponsored by Aswan University. The principal investigator is Hani Ahmed Farouk, Assist.Prof. at Obstetrics and Gynecology,Faculty of Medicine,Aswan University. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology